ADORA2A and neoplasm: Frequencies of ASCs were reduced in adenosine-rich tumor regions, and A2AR triggering impaired B cell differentiation to ASCs and immunoglobulin production in vitro, an effect fully restored by the specific A2AR antagonist inupadenant.